Home
Home | New Titles | Focus Reports | Custom Research | Browse Catalog  |  About Us |  Contact Us   |  

View Cart  |  Complete Purchase  |  View Wish List  |  My Reading Room  |  Edit Account  |  Purchase History  |  Register  |  Login  
       
In Vitro Diagnostic Products to 2016

 


 





Study #: 2923
Document Type: Industry Study
Date Published: Jul-2012
Format:
   Full study: PDF
   Section, Pages, Tables and Charts: HTML
Pages: 365
Full Study Price: $5,100.00
       

    

US demand for in vitro (IVD) diagnostic products will rise 6.1 percent annually to $24.7 billion in 2016. Molecular diagnostic products will grow the fastest due to their advantages in the detection of infectious diseases, tumors and genetic disorders. Hospital labs will continue to comprise the largest and most diverse market.

This study analyzes the $18.4 billion US IVD products industry, with forecasts for 2016 and 2021 by product type (e.g., clinical chemistry, immunoassay, molecular diagnostic, blood testing, cellular analysis, anatomical pathology, microbiology), application (e.g., infectious disease testing, cancer testing, diabetes testing, heart disease testing, blood grouping and screening, drug testing) and market (e.g., hospitals, independent clinical laboratories).

The study also considers market environment factors, details industry structure, evaluates company market share and profiles 27 industry players, including Roche, Johnson & Johnson and Danahar).

 









Freedonia Footer Links
Career Opportunities   Press Contact   Partner Programs   User Agreement   Privacy Policy   FAQ’s/Help   Site Map   Study Index




E-mail: info@freedoniagroup.com • telephone: +1 440.684.9600 • fax: +1 440.646.0484      
767 Beta Dr. Cleveland Ohio 44143 USA

Copyright © 2013 - Freedonia - All Rights Reserved